APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Epidemiology

Compare research editions
View pricing & licenses

Selected research

Industry Research

Artificial Intelligence in Epidemiology Industry Research Report 2026

4 January 2026141 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Epidemiology Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Epidemiology Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Epidemiology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Epidemiology Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Epidemiology Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Epidemiology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Artificial Intelligence in Epidemiology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Artificial Intelligence in Epidemiology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Artificial Intelligence in Epidemiology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Artificial Intelligence in Epidemiology include Abbott Informatics, AdvancedMD, Agilent Technologies, Allscripts Healthcare, Athenahealth, Autoscribe Informatics, Cerner Corporation, Change Healthcare and Cognizant, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Artificial Intelligence in Epidemiology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Artificial Intelligence in Epidemiology.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Artificial Intelligence in Epidemiology Market by Company

Abbott Informatics

AdvancedMD

Agilent Technologies

Allscripts Healthcare

Athenahealth

Autoscribe Informatics

Cerner Corporation

Change Healthcare

Cognizant

CPSI

CureMD Healthcare

eClinicalWorks

e-Mds Inc.

Epic Systems

GE Healthcare

Google

Graphcore

Greenway Health

IBM

Intel

InterSystems

Kareo

Medhost

Meditech

Medtronic

Micron Technology

Microsoft

NextGen Healthcare

Nvidia

Optum Inc.

Artificial Intelligence in Epidemiology Segment by Type

Hardware Technology

Software Technology

Artificial Intelligence in Epidemiology Segment by Application

Disease and Syndromic Surveillance

Infection Prediction and Forecasting

Immunization Information Systems

Public Sentiment Analysis

Environmental Impact Analysis

Drug Discovery, Safety, and Risk Analysis

Monitoring Population and Incidence

Knowledge Representation and Mass Notification

Artificial Intelligence in Epidemiology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Epidemiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Epidemiology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Epidemiology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Artificial Intelligence in Epidemiology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Artificial Intelligence in Epidemiology Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Artificial Intelligence in Epidemiology Revenue Market Share by Type (2021-2026) Table 7. Global Artificial Intelligence in Epidemiology Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Artificial Intelligence in Epidemiology Revenue Market Share by Type (2027-2032) Table 9. Global Artificial Intelligence in Epidemiology Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Artificial Intelligence in Epidemiology Revenue Market Share by Application (2021-2026) Table 11. Global Artificial Intelligence in Epidemiology Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Artificial Intelligence in Epidemiology Revenue Market Share by Application (2027-2032) Table 13. Global Artificial Intelligence in Epidemiology Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Artificial Intelligence in Epidemiology Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Artificial Intelligence in Epidemiology Market Share by Region (2021-2026) Table 16. Global Artificial Intelligence in Epidemiology Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Artificial Intelligence in Epidemiology Market Share by Region (2027-2032) Table 18. Artificial Intelligence in Epidemiology Industry Trends Table 19. Artificial Intelligence in Epidemiology Industry Drivers Table 20. Artificial Intelligence in Epidemiology Industry Opportunities and Challenges Table 21. Artificial Intelligence in Epidemiology Market Restraints Table 22. Global Top Artificial Intelligence in Epidemiology Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Artificial Intelligence in Epidemiology Revenue Market Share by Players (2021-2026) Table 24. Global Artificial Intelligence in Epidemiology Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Artificial Intelligence in Epidemiology, Headquarters and Area Served Table 26. Global Artificial Intelligence in Epidemiology Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Artificial Intelligence in Epidemiology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Artificial Intelligence in Epidemiology Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Artificial Intelligence in Epidemiology Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Artificial Intelligence in Epidemiology Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Artificial Intelligence in Epidemiology Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Artificial Intelligence in Epidemiology Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Artificial Intelligence in Epidemiology Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Artificial Intelligence in Epidemiology Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Artificial Intelligence in Epidemiology Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Artificial Intelligence in Epidemiology Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Artificial Intelligence in Epidemiology Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Artificial Intelligence in Epidemiology Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Artificial Intelligence in Epidemiology Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Artificial Intelligence in Epidemiology Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Country (2027-2032) & (US$ Million) Table 45. Abbott Informatics Company Information Table 46. Abbott Informatics Business Overview Table 47. Abbott Informatics Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 48. Abbott Informatics Artificial Intelligence in Epidemiology Product Portfolio Table 49. Abbott Informatics Recent Developments Table 50. AdvancedMD Company Information Table 51. AdvancedMD Business Overview Table 52. AdvancedMD Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 53. AdvancedMD Artificial Intelligence in Epidemiology Product Portfolio Table 54. AdvancedMD Recent Developments Table 55. Agilent Technologies Company Information Table 56. Agilent Technologies Business Overview Table 57. Agilent Technologies Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 58. Agilent Technologies Artificial Intelligence in Epidemiology Product Portfolio Table 59. Agilent Technologies Recent Developments Table 60. Allscripts Healthcare Company Information Table 61. Allscripts Healthcare Business Overview Table 62. Allscripts Healthcare Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 63. Allscripts Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 64. Allscripts Healthcare Recent Developments Table 65. Athenahealth Company Information Table 66. Athenahealth Business Overview Table 67. Athenahealth Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 68. Athenahealth Artificial Intelligence in Epidemiology Product Portfolio Table 69. Athenahealth Recent Developments Table 70. Autoscribe Informatics Company Information Table 71. Autoscribe Informatics Business Overview Table 72. Autoscribe Informatics Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 73. Autoscribe Informatics Artificial Intelligence in Epidemiology Product Portfolio Table 74. Autoscribe Informatics Recent Developments Table 75. Cerner Corporation Company Information Table 76. Cerner Corporation Business Overview Table 77. Cerner Corporation Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 78. Cerner Corporation Artificial Intelligence in Epidemiology Product Portfolio Table 79. Cerner Corporation Recent Developments Table 80. Change Healthcare Company Information Table 81. Change Healthcare Business Overview Table 82. Change Healthcare Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 83. Change Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 84. Change Healthcare Recent Developments Table 85. Cognizant Company Information Table 86. Cognizant Business Overview Table 87. Cognizant Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 88. Cognizant Artificial Intelligence in Epidemiology Product Portfolio Table 89. Cognizant Recent Developments Table 90. CPSI Company Information Table 91. CPSI Business Overview Table 92. CPSI Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 93. CPSI Artificial Intelligence in Epidemiology Product Portfolio Table 94. CPSI Recent Developments Table 95. CureMD Healthcare Company Information Table 96. CureMD Healthcare Business Overview Table 97. CureMD Healthcare Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 98. CureMD Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 99. CureMD Healthcare Recent Developments Table 100. eClinicalWorks Company Information Table 101. eClinicalWorks Business Overview Table 102. eClinicalWorks Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 103. eClinicalWorks Artificial Intelligence in Epidemiology Product Portfolio Table 104. eClinicalWorks Recent Developments Table 105. e-Mds Inc. Company Information Table 106. e-Mds Inc. Business Overview Table 107. e-Mds Inc. Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 108. e-Mds Inc. Artificial Intelligence in Epidemiology Product Portfolio Table 109. e-Mds Inc. Recent Developments Table 110. Epic Systems Company Information Table 111. Epic Systems Business Overview Table 112. Epic Systems Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 113. Epic Systems Artificial Intelligence in Epidemiology Product Portfolio Table 114. Epic Systems Recent Developments Table 115. GE Healthcare Company Information Table 116. GE Healthcare Business Overview Table 117. GE Healthcare Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 118. GE Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 119. GE Healthcare Recent Developments Table 120. Google Company Information Table 121. Google Business Overview Table 122. Google Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 123. Google Artificial Intelligence in Epidemiology Product Portfolio Table 124. Google Recent Developments Table 125. Graphcore Company Information Table 126. Graphcore Business Overview Table 127. Graphcore Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 128. Graphcore Artificial Intelligence in Epidemiology Product Portfolio Table 129. Graphcore Recent Developments Table 130. Greenway Health Company Information Table 131. Greenway Health Business Overview Table 132. Greenway Health Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 133. Greenway Health Artificial Intelligence in Epidemiology Product Portfolio Table 134. Greenway Health Recent Developments Table 135. IBM Company Information Table 136. IBM Business Overview Table 137. IBM Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 138. IBM Artificial Intelligence in Epidemiology Product Portfolio Table 139. IBM Recent Developments Table 140. Intel Company Information Table 141. Intel Business Overview Table 142. Intel Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 143. Intel Artificial Intelligence in Epidemiology Product Portfolio Table 144. Intel Recent Developments Table 145. InterSystems Company Information Table 146. InterSystems Business Overview Table 147. InterSystems Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 148. InterSystems Artificial Intelligence in Epidemiology Product Portfolio Table 149. InterSystems Recent Developments Table 150. Kareo Company Information Table 151. Kareo Business Overview Table 152. Kareo Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 153. Kareo Artificial Intelligence in Epidemiology Product Portfolio Table 154. Kareo Recent Developments Table 155. Medhost Company Information Table 156. Medhost Business Overview Table 157. Medhost Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 158. Medhost Artificial Intelligence in Epidemiology Product Portfolio Table 159. Medhost Recent Developments Table 160. Meditech Company Information Table 161. Meditech Business Overview Table 162. Meditech Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 163. Meditech Artificial Intelligence in Epidemiology Product Portfolio Table 164. Meditech Recent Developments Table 165. Medtronic Company Information Table 166. Medtronic Business Overview Table 167. Medtronic Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 168. Medtronic Artificial Intelligence in Epidemiology Product Portfolio Table 169. Medtronic Recent Developments Table 170. Micron Technology Company Information Table 171. Micron Technology Business Overview Table 172. Micron Technology Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 173. Micron Technology Artificial Intelligence in Epidemiology Product Portfolio Table 174. Micron Technology Recent Developments Table 175. Microsoft Company Information Table 176. Microsoft Business Overview Table 177. Microsoft Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 178. Microsoft Artificial Intelligence in Epidemiology Product Portfolio Table 179. Microsoft Recent Developments Table 180. NextGen Healthcare Company Information Table 181. NextGen Healthcare Business Overview Table 182. NextGen Healthcare Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 183. NextGen Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 184. NextGen Healthcare Recent Developments Table 185. Nvidia Company Information Table 186. Nvidia Business Overview Table 187. Nvidia Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 188. Nvidia Artificial Intelligence in Epidemiology Product Portfolio Table 189. Nvidia Recent Developments Table 190. Optum Inc. Company Information Table 191. Optum Inc. Business Overview Table 192. Optum Inc. Revenue in Artificial Intelligence in Epidemiology Business (2021-2026) & (US$ Million) Table 193. Optum Inc. Artificial Intelligence in Epidemiology Product Portfolio Table 194. Optum Inc. Recent Developments Table 195. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Artificial Intelligence in Epidemiology Product Image Figure 5. Global Artificial Intelligence in Epidemiology Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Artificial Intelligence in Epidemiology Market Share by Type: 2025 VS 2032 Figure 7. Hardware Technology Product Figure 8. Software Technology Product Figure 9. Global Artificial Intelligence in Epidemiology Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Artificial Intelligence in Epidemiology Market Share by Application: 2025 VS 2032 Figure 11. Disease and Syndromic Surveillance Product Figure 12. Infection Prediction and Forecasting Product Figure 13. Immunization Information Systems Product Figure 14. Public Sentiment Analysis Product Figure 15. Environmental Impact Analysis Product Figure 16. Drug Discovery, Safety, and Risk Analysis Product Figure 17. Monitoring Population and Incidence Product Figure 18. Knowledge Representation and Mass Notification Product Figure 19. Global Artificial Intelligence in Epidemiology Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 20. Global Artificial Intelligence in Epidemiology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Artificial Intelligence in Epidemiology Market Share by Region: 2025 VS 2032 Figure 22. Global Artificial Intelligence in Epidemiology Market Share by Players in 2025 Figure 23. Global Artificial Intelligence in Epidemiology Manufacturers Established Date Figure 24. Global Top 5 and 10 Artificial Intelligence in Epidemiology Players Market Share by Revenue in 2025 Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. North America Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 28. United States Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Canada Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Mexico Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 31. Europe Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 33. Germany Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. France Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. U.K. Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Italy Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Spain Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Russia Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Netherlands Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Nordic Countries Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 43. China Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Japan Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. South Korea Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. India Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. India Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 48. Australia Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. China Taiwan Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Southeast Asia Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. South America Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. South America Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 53. Brazil Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Argentina Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Chile Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Colombia Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 57. Peru Artificial Intelligence in Epidemiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 58. Abbott Informatics Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 59. AdvancedMD Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 60. Agilent Technologies Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 61. Allscripts Healthcare Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 62. Athenahealth Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 63. Autoscribe Informatics Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 64. Cerner Corporation Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 65. Change Healthcare Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 66. Cognizant Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 67. CPSI Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 68. CureMD Healthcare Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 69. eClinicalWorks Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 70. e-Mds Inc. Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 71. Epic Systems Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 72. GE Healthcare Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 73. Google Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 74. Graphcore Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 75. Greenway Health Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 76. IBM Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 77. Intel Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 78. InterSystems Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 79. Kareo Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 80. Medhost Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 81. Meditech Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 82. Medtronic Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 83. Micron Technology Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 84. Microsoft Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 85. NextGen Healthcare Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 86. Nvidia Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026) Figure 87. Optum Inc. Revenue Growth Rate in Artificial Intelligence in Epidemiology Business (2021-2026)

Scope & coverage.

Types
  • Hardware Technology
  • Software Technology
Applications
  • Disease and Syndromic Surveillance
  • Infection Prediction and Forecasting
  • Immunization Information Systems
  • Public Sentiment Analysis
  • Environmental Impact Analysis
  • Drug Discovery, Safety, and Risk Analysis
  • Monitoring Population and Incidence
  • Knowledge Representation and Mass Notification
Companies covered
  • Abbott Informatics
  • AdvancedMD
  • Agilent Technologies
  • Allscripts Healthcare
  • Athenahealth
  • Autoscribe Informatics
  • Cerner Corporation
  • Change Healthcare
  • Cognizant
  • CPSI
  • CureMD Healthcare
  • eClinicalWorks
  • e-Mds Inc.
  • Epic Systems
  • GE Healthcare
  • Google
  • Graphcore
  • Greenway Health
  • IBM
  • Intel
  • InterSystems
  • Kareo
  • Medhost
  • Meditech
  • Medtronic
  • Micron Technology
  • Microsoft
  • NextGen Healthcare
  • Nvidia
  • Optum Inc.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Artificial Intelligence in Epidemiology by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Hardware Technology
  5. 2.2.3 Software Technology
  6. 2.3 Artificial Intelligence in Epidemiology by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Disease and Syndromic Surveillance
  9. 2.3.3 Infection Prediction and Forecasting
  10. 2.3.4 Immunization Information Systems
  11. 2.3.5 Public Sentiment Analysis
  12. 2.3.6 Environmental Impact Analysis
  13. 2.3.7 Drug Discovery, Safety, and Risk Analysis
  14. 2.3.8 Monitoring Population and Incidence
  15. 2.3.9 Knowledge Representation and Mass Notification
  16. 2.4 Assumptions and Limitations
3 Artificial Intelligence in Epidemiology Breakdown Data by Type
  1. 3.1 Global Artificial Intelligence in Epidemiology Historic Market Size by Type (2021-2026)
  2. 3.2 Global Artificial Intelligence in Epidemiology Forecasted Market Size by Type (2027-2032)
4 Artificial Intelligence in Epidemiology Breakdown Data by Application
  1. 4.1 Global Artificial Intelligence in Epidemiology Historic Market Size by Application (2021-2026)
  2. 4.2 Global Artificial Intelligence in Epidemiology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Artificial Intelligence in Epidemiology Market Perspective (2021-2032)
  2. 5.2 Global Artificial Intelligence in Epidemiology Growth Trends by Region
  3. 5.2.1 Global Artificial Intelligence in Epidemiology Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Artificial Intelligence in Epidemiology Historic Market Size by Region (2021-2026)
  5. 5.2.3 Artificial Intelligence in Epidemiology Forecasted Market Size by Region (2027-2032)
  6. 5.3 Artificial Intelligence in Epidemiology Market Dynamics
  7. 5.3.1 Artificial Intelligence in Epidemiology Industry Trends
  8. 5.3.2 Artificial Intelligence in Epidemiology Market Drivers
  9. 5.3.3 Artificial Intelligence in Epidemiology Market Challenges
  10. 5.3.4 Artificial Intelligence in Epidemiology Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Artificial Intelligence in Epidemiology Players by Revenue
  2. 6.1.1 Global Top Artificial Intelligence in Epidemiology Players by Revenue (2021-2026)
  3. 6.1.2 Global Artificial Intelligence in Epidemiology Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Artificial Intelligence in Epidemiology Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Artificial Intelligence in Epidemiology Head Office and Area Served
  6. 6.4 Global Artificial Intelligence in Epidemiology Players, Product Type & Application
  7. 6.5 Global Artificial Intelligence in Epidemiology Manufacturers Established Date
  8. 6.6 Global Artificial Intelligence in Epidemiology Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Artificial Intelligence in Epidemiology Market Size (2021-2032)
  2. 7.2 North America Artificial Intelligence in Epidemiology Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Artificial Intelligence in Epidemiology Market Size by Country (2021-2026)
  4. 7.4 North America Artificial Intelligence in Epidemiology Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Artificial Intelligence in Epidemiology Market Size (2021-2032)
  2. 8.2 Europe Artificial Intelligence in Epidemiology Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Artificial Intelligence in Epidemiology Market Size by Country (2021-2026)
  4. 8.4 Europe Artificial Intelligence in Epidemiology Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Artificial Intelligence in Epidemiology Market Size (2021-2032)
  2. 9.2 Asia-Pacific Artificial Intelligence in Epidemiology Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Artificial Intelligence in Epidemiology Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Artificial Intelligence in Epidemiology Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Artificial Intelligence in Epidemiology Market Size (2021-2032)
  2. 10.2 South America Artificial Intelligence in Epidemiology Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Artificial Intelligence in Epidemiology Market Size by Country (2021-2026)
  4. 10.4 South America Artificial Intelligence in Epidemiology Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Artificial Intelligence in Epidemiology Market Size (2021-2032)
  2. 11.2 Middle East & Africa Artificial Intelligence in Epidemiology Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Abbott Informatics
  2. 12.1.1 Abbott Informatics Company Information
  3. 12.1.2 Abbott Informatics Business Overview
  4. 12.1.3 Abbott Informatics Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  5. 12.1.4 Abbott Informatics Artificial Intelligence in Epidemiology Product Portfolio
  6. 12.1.5 Abbott Informatics Recent Developments
  7. 12.2 AdvancedMD
  8. 12.2.1 AdvancedMD Company Information
  9. 12.2.2 AdvancedMD Business Overview
  10. 12.2.3 AdvancedMD Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  11. 12.2.4 AdvancedMD Artificial Intelligence in Epidemiology Product Portfolio
  12. 12.2.5 AdvancedMD Recent Developments
  13. 12.3 Agilent Technologies
  14. 12.3.1 Agilent Technologies Company Information
  15. 12.3.2 Agilent Technologies Business Overview
  16. 12.3.3 Agilent Technologies Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  17. 12.3.4 Agilent Technologies Artificial Intelligence in Epidemiology Product Portfolio
  18. 12.3.5 Agilent Technologies Recent Developments
  19. 12.4 Allscripts Healthcare
  20. 12.4.1 Allscripts Healthcare Company Information
  21. 12.4.2 Allscripts Healthcare Business Overview
  22. 12.4.3 Allscripts Healthcare Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  23. 12.4.4 Allscripts Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  24. 12.4.5 Allscripts Healthcare Recent Developments
  25. 12.5 Athenahealth
  26. 12.5.1 Athenahealth Company Information
  27. 12.5.2 Athenahealth Business Overview
  28. 12.5.3 Athenahealth Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  29. 12.5.4 Athenahealth Artificial Intelligence in Epidemiology Product Portfolio
  30. 12.5.5 Athenahealth Recent Developments
  31. 12.6 Autoscribe Informatics
  32. 12.6.1 Autoscribe Informatics Company Information
  33. 12.6.2 Autoscribe Informatics Business Overview
  34. 12.6.3 Autoscribe Informatics Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  35. 12.6.4 Autoscribe Informatics Artificial Intelligence in Epidemiology Product Portfolio
  36. 12.6.5 Autoscribe Informatics Recent Developments
  37. 12.7 Cerner Corporation
  38. 12.7.1 Cerner Corporation Company Information
  39. 12.7.2 Cerner Corporation Business Overview
  40. 12.7.3 Cerner Corporation Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  41. 12.7.4 Cerner Corporation Artificial Intelligence in Epidemiology Product Portfolio
  42. 12.7.5 Cerner Corporation Recent Developments
  43. 12.8 Change Healthcare
  44. 12.8.1 Change Healthcare Company Information
  45. 12.8.2 Change Healthcare Business Overview
  46. 12.8.3 Change Healthcare Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  47. 12.8.4 Change Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  48. 12.8.5 Change Healthcare Recent Developments
  49. 12.9 Cognizant
  50. 12.9.1 Cognizant Company Information
  51. 12.9.2 Cognizant Business Overview
  52. 12.9.3 Cognizant Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  53. 12.9.4 Cognizant Artificial Intelligence in Epidemiology Product Portfolio
  54. 12.9.5 Cognizant Recent Developments
  55. 12.10 CPSI
  56. 12.10.1 CPSI Company Information
  57. 12.10.2 CPSI Business Overview
  58. 12.10.3 CPSI Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  59. 12.10.4 CPSI Artificial Intelligence in Epidemiology Product Portfolio
  60. 12.10.5 CPSI Recent Developments
  61. 12.11 CureMD Healthcare
  62. 12.11.1 CureMD Healthcare Company Information
  63. 12.11.2 CureMD Healthcare Business Overview
  64. 12.11.3 CureMD Healthcare Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  65. 12.11.4 CureMD Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  66. 12.11.5 CureMD Healthcare Recent Developments
  67. 12.12 eClinicalWorks
  68. 12.12.1 eClinicalWorks Company Information
  69. 12.12.2 eClinicalWorks Business Overview
  70. 12.12.3 eClinicalWorks Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  71. 12.12.4 eClinicalWorks Artificial Intelligence in Epidemiology Product Portfolio
  72. 12.12.5 eClinicalWorks Recent Developments
  73. 12.13 e-Mds Inc.
  74. 12.13.1 e-Mds Inc. Company Information
  75. 12.13.2 e-Mds Inc. Business Overview
  76. 12.13.3 e-Mds Inc. Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  77. 12.13.4 e-Mds Inc. Artificial Intelligence in Epidemiology Product Portfolio
  78. 12.13.5 e-Mds Inc. Recent Developments
  79. 12.14 Epic Systems
  80. 12.14.1 Epic Systems Company Information
  81. 12.14.2 Epic Systems Business Overview
  82. 12.14.3 Epic Systems Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  83. 12.14.4 Epic Systems Artificial Intelligence in Epidemiology Product Portfolio
  84. 12.14.5 Epic Systems Recent Developments
  85. 12.15 GE Healthcare
  86. 12.15.1 GE Healthcare Company Information
  87. 12.15.2 GE Healthcare Business Overview
  88. 12.15.3 GE Healthcare Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  89. 12.15.4 GE Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  90. 12.15.5 GE Healthcare Recent Developments
  91. 12.16 Google
  92. 12.16.1 Google Company Information
  93. 12.16.2 Google Business Overview
  94. 12.16.3 Google Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  95. 12.16.4 Google Artificial Intelligence in Epidemiology Product Portfolio
  96. 12.16.5 Google Recent Developments
  97. 12.17 Graphcore
  98. 12.17.1 Graphcore Company Information
  99. 12.17.2 Graphcore Business Overview
  100. 12.17.3 Graphcore Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  101. 12.17.4 Graphcore Artificial Intelligence in Epidemiology Product Portfolio
  102. 12.17.5 Graphcore Recent Developments
  103. 12.18 Greenway Health
  104. 12.18.1 Greenway Health Company Information
  105. 12.18.2 Greenway Health Business Overview
  106. 12.18.3 Greenway Health Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  107. 12.18.4 Greenway Health Artificial Intelligence in Epidemiology Product Portfolio
  108. 12.18.5 Greenway Health Recent Developments
  109. 12.19 IBM
  110. 12.19.1 IBM Company Information
  111. 12.19.2 IBM Business Overview
  112. 12.19.3 IBM Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  113. 12.19.4 IBM Artificial Intelligence in Epidemiology Product Portfolio
  114. 12.19.5 IBM Recent Developments
  115. 12.20 Intel
  116. 12.20.1 Intel Company Information
  117. 12.20.2 Intel Business Overview
  118. 12.20.3 Intel Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  119. 12.20.4 Intel Artificial Intelligence in Epidemiology Product Portfolio
  120. 12.20.5 Intel Recent Developments
  121. 12.21 InterSystems
  122. 12.21.1 InterSystems Company Information
  123. 12.21.2 InterSystems Business Overview
  124. 12.21.3 InterSystems Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  125. 12.21.4 InterSystems Artificial Intelligence in Epidemiology Product Portfolio
  126. 12.21.5 InterSystems Recent Developments
  127. 12.22 Kareo
  128. 12.22.1 Kareo Company Information
  129. 12.22.2 Kareo Business Overview
  130. 12.22.3 Kareo Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  131. 12.22.4 Kareo Artificial Intelligence in Epidemiology Product Portfolio
  132. 12.22.5 Kareo Recent Developments
  133. 12.23 Medhost
  134. 12.23.1 Medhost Company Information
  135. 12.23.2 Medhost Business Overview
  136. 12.23.3 Medhost Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  137. 12.23.4 Medhost Artificial Intelligence in Epidemiology Product Portfolio
  138. 12.23.5 Medhost Recent Developments
  139. 12.24 Meditech
  140. 12.24.1 Meditech Company Information
  141. 12.24.2 Meditech Business Overview
  142. 12.24.3 Meditech Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  143. 12.24.4 Meditech Artificial Intelligence in Epidemiology Product Portfolio
  144. 12.24.5 Meditech Recent Developments
  145. 12.25 Medtronic
  146. 12.25.1 Medtronic Company Information
  147. 12.25.2 Medtronic Business Overview
  148. 12.25.3 Medtronic Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  149. 12.25.4 Medtronic Artificial Intelligence in Epidemiology Product Portfolio
  150. 12.25.5 Medtronic Recent Developments
  151. 12.26 Micron Technology
  152. 12.26.1 Micron Technology Company Information
  153. 12.26.2 Micron Technology Business Overview
  154. 12.26.3 Micron Technology Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  155. 12.26.4 Micron Technology Artificial Intelligence in Epidemiology Product Portfolio
  156. 12.26.5 Micron Technology Recent Developments
  157. 12.27 Microsoft
  158. 12.27.1 Microsoft Company Information
  159. 12.27.2 Microsoft Business Overview
  160. 12.27.3 Microsoft Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  161. 12.27.4 Microsoft Artificial Intelligence in Epidemiology Product Portfolio
  162. 12.27.5 Microsoft Recent Developments
  163. 12.28 NextGen Healthcare
  164. 12.28.1 NextGen Healthcare Company Information
  165. 12.28.2 NextGen Healthcare Business Overview
  166. 12.28.3 NextGen Healthcare Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  167. 12.28.4 NextGen Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  168. 12.28.5 NextGen Healthcare Recent Developments
  169. 12.29 Nvidia
  170. 12.29.1 Nvidia Company Information
  171. 12.29.2 Nvidia Business Overview
  172. 12.29.3 Nvidia Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  173. 12.29.4 Nvidia Artificial Intelligence in Epidemiology Product Portfolio
  174. 12.29.5 Nvidia Recent Developments
  175. 12.30 Optum Inc.
  176. 12.30.1 Optum Inc. Company Information
  177. 12.30.2 Optum Inc. Business Overview
  178. 12.30.3 Optum Inc. Revenue in Artificial Intelligence in Epidemiology Business (2021-2026)
  179. 12.30.4 Optum Inc. Artificial Intelligence in Epidemiology Product Portfolio
  180. 12.30.5 Optum Inc. Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst